38090817|t|Therapeutic potential of natural antisense transcripts and various mechanisms involved for clinical applications and disease prevention.
38090817|a|Antisense transcription, a prevalent occurrence in mammalian genomes, gives rise to natural antisense transcripts (NATs) as RNA molecules. These NATs serve as agents of diverse transcriptional and post-transcriptional regulatory mechanisms, playing crucial roles in various biological processes vital for cell function and immune response. However, when their normal functions are disrupted, they can contribute to human diseases. This comprehensive review aims to establish the molecular foundation linking NATs to the development of disorders like cancer, neurodegenerative conditions, and cardiovascular ailments. Additionally, we evaluate the potential of oligonucleotide-based therapies targeting NATs, presenting both their advantages and limitations, while also highlighting the latest advancements in this promising realm of clinical investigation.Abbreviations: NATs- Natural antisense transcripts, PRC1- Polycomb Repressive Complex 1, PRC2- Polycomb Repressive Complex 2, ADARs- Adenosine deaminases acting on RNA, BDNF-AS- Brain-derived neurotrophic factor antisense transcript, ASOs- Antisense oligonucleotides, SINEUPs- Inverted SINEB2 sequence-mediated upregulating molecules, PTBP1- Polypyrimidine tract binding protein-1, HNRNPK- heterogeneous nuclear ribonucleoprotein K, MAPT-AS1- microtubule-associated protein tau antisense 1, KCNQ1OT- (KCNQ1 opposite strand/antisense transcript 1, ERK- extracellular signal-regulated kinase 1, USP14- ubiquitin-specific protease 14, EGF- Epidermal growth factor, LSD1- Lysine Specific Demethylase 1, ANRIL- Antisense Noncoding RNA in the INK4 Locus, BWS- Beckwith-Wiedemann syndrome, VEGFA- Vascular Endothelial Growth component A.
38090817	552	557	human	Species	9606
38090817	687	693	cancer	Disease	MESH:D009369
38090817	695	723	neurodegenerative conditions	Disease	MESH:D019636
38090817	729	752	cardiovascular ailments	Disease	MESH:D002318
38090817	797	812	oligonucleotide	Chemical	MESH:D009841
38090817	1045	1049	PRC1	Gene	9055
38090817	1162	1166	BDNF	Gene	627
38090817	1171	1204	Brain-derived neurotrophic factor	Gene	627
38090817	1328	1333	PTBP1	Gene	5725
38090817	1335	1373	Polypyrimidine tract binding protein-1	Gene	5725
38090817	1375	1381	HNRNPK	Gene	3190
38090817	1383	1424	heterogeneous nuclear ribonucleoprotein K	Gene	3190
38090817	1426	1430	MAPT	Gene	4137
38090817	1431	1434	AS1	Gene	5729
38090817	1484	1491	KCNQ1OT	Gene	3784
38090817	1494	1499	KCNQ1	Gene	3784
38090817	1540	1543	ERK	Gene	5594
38090817	1545	1584	extracellular signal-regulated kinase 1	Gene	5594
38090817	1586	1591	USP14	Gene	9097
38090817	1625	1628	EGF	Gene	1950
38090817	1630	1653	Epidermal growth factor	Gene	1950
38090817	1655	1659	LSD1	Gene	23028
38090817	1692	1697	ANRIL	Gene	100048912
38090817	1730	1734	INK4	Gene	1029
38090817	1742	1774	BWS- Beckwith-Wiedemann syndrome	Disease	MESH:D001506
38090817	1776	1781	VEGFA	Gene	7422
38090817	Association	MESH:D001506	1029

